Prot #CAIN457AUS05T: A Multicenter Study with a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients with Ichthyoses

Project: Research project

Project Details

StatusFinished
Effective start/end date3/1/16 → 12/31/20

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CAIN457AUS05T)